208 related articles for article (PubMed ID: 24417912)
1. Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.
Martino M; Postorino M; Gallo GA; Messina G; Neri S; Piro E; Gentile M; Moscato T; Monteleone R; Fedele R; Mazzone C; Console G; Penna G; Alati C; Vincelli ID; Irrera G; Musolino C; Ronco F; Molica S; Morabito F
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):148-54. PubMed ID: 24417912
[TBL] [Abstract][Full Text] [Related]
2. Total therapy with tandem transplants for newly diagnosed multiple myeloma.
Barlogie B; Jagannath S; Desikan KR; Mattox S; Vesole D; Siegel D; Tricot G; Munshi N; Fassas A; Singhal S; Mehta J; Anaissie E; Dhodapkar D; Naucke S; Cromer J; Sawyer J; Epstein J; Spoon D; Ayers D; Cheson B; Crowley J
Blood; 1999 Jan; 93(1):55-65. PubMed ID: 9864146
[TBL] [Abstract][Full Text] [Related]
3. Maintenance therapy for remission in myeloma with Intron A following high-dose melphalan and either an autologous bone marrow transplantation or peripheral stem cell rescue.
Powles R; Raje N; Cunningham D; Malpas J; Milan S; Horton C; Mehta J; Singhal S; Viner C; Treleaven J
Stem Cells; 1995 Aug; 13 Suppl 2():114-7. PubMed ID: 8520498
[TBL] [Abstract][Full Text] [Related]
4. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma.
Harousseau JL; Attal M; Divine M; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M; Abgrall JF
Stem Cells; 1995 Aug; 13 Suppl 2():132-9. PubMed ID: 8520502
[TBL] [Abstract][Full Text] [Related]
5. Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.
Alegre A; Díaz-Mediavilla J; San-Miguel J; Martínez R; García Laraña J; Sureda A; Lahuerta JJ; Morales D; Bladé J; Caballero D; De la Rubia J; Escudero A; Díez-Martín JL; Hernández-Navarro F; Rifón J; Odriozola J; Brunet S; De la Serna J; Besalduch J; Vidal MJ; Solano C; Leon A; Sánchez JJ; Martínez-Chamorro C; Fernández-Rañada JM
Bone Marrow Transplant; 1998 Jan; 21(2):133-40. PubMed ID: 9489629
[TBL] [Abstract][Full Text] [Related]
6. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
[TBL] [Abstract][Full Text] [Related]
7. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
[TBL] [Abstract][Full Text] [Related]
8. [Progress in the treatment of multiple myeloma].
Wada M; Mizoguchi H
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1079-88. PubMed ID: 9239160
[TBL] [Abstract][Full Text] [Related]
9. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma.
Cunningham D; Paz-Ares L; Milan S; Powles R; Nicolson M; Hickish T; Selby P; Treleavan J; Viner C; Malpas J
J Clin Oncol; 1994 Apr; 12(4):759-63. PubMed ID: 8151319
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy and autologous bone marrow transplantation for myeloma.
McElwain TJ; Selby PJ; Gore ME; Viner C; Meldrum M; Millar BC; Malpas JS
Eur J Haematol Suppl; 1989; 51():152-6. PubMed ID: 2697587
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of multiple myeloma with high-dose chemotherapy and transplantation of autologous hematopoietic stem cells and subsequent maintenance therapy with interferon alfa-2b or interferon alfa 2b and dexamethasone. Report of the ongoing study of the "4W" Czech Myeloma Group].
Adam Z; Krejcí M; Bacovský J; Hejlová N; Kuca B; Svojgrová M; Franková H; Gumulec J; Janca J; Veprek K; Januska B; Lehanka F; Rezek Z; Praskac P; Cahová S; Vránová M; Papajík T; Králová E; Novotná J; Scudla V; Koza V; Drbal J; Faber E; Mareschová I; Hájek R
Vnitr Lek; 1998 Jul; 44(7):400-8. PubMed ID: 9748876
[TBL] [Abstract][Full Text] [Related]
12. Busulfan and melphalan as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma.
Alegre A; Lamana M; Arranz R; Fernández-Villalta MJ; Tomás JF; Figuera A; Cámara R; Steegman JL; Casado F; Requena MJ
Br J Haematol; 1995 Oct; 91(2):380-6. PubMed ID: 8547079
[TBL] [Abstract][Full Text] [Related]
13. Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated.
Bladé J; San Miguel JF; Fontanillas M; Alcalá A; Maldonado J; García-Conde J; Conde E; Conzález-Brito G; Moro MJ; Escudero ML; Trujillo J; Pascual A; Rozman C; Estapé J; Montserrat E
J Clin Oncol; 1996 Jul; 14(7):2167-73. PubMed ID: 8683251
[TBL] [Abstract][Full Text] [Related]
14. Intensive treatment of multiple myeloma and criteria for complete remission.
Gore ME; Selby PJ; Viner C; Clark PI; Meldrum M; Millar B; Bell J; Maitland JA; Milan S; Judson IR
Lancet; 1989 Oct; 2(8668):879-82. PubMed ID: 2571812
[TBL] [Abstract][Full Text] [Related]
15. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma.
Harousseau JL; Attal M; Divine M; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M; Abgrall JF
Blood; 1995 Jun; 85(11):3077-85. PubMed ID: 7756641
[TBL] [Abstract][Full Text] [Related]
16. High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.
Fermand JP; Ravaud P; Chevret S; Divine M; Leblond V; Belanger C; Macro M; Pertuiset E; Dreyfus F; Mariette X; Boccacio C; Brouet JC
Blood; 1998 Nov; 92(9):3131-6. PubMed ID: 9787148
[TBL] [Abstract][Full Text] [Related]
17. VAD chemotherapy as remission induction for multiple myeloma.
Anderson H; Scarffe JH; Ranson M; Young R; Wieringa GS; Morgenstern GR; Fitzsimmons L; Ryder D
Br J Cancer; 1995 Feb; 71(2):326-30. PubMed ID: 7841049
[TBL] [Abstract][Full Text] [Related]
18. Intensive combined therapy for previously untreated aggressive myeloma.
Attal M; Huguet F; Schlaifer D; Payen C; Laroche M; Fournie B; Mazieres B; Pris J; Laurent G
Blood; 1992 Mar; 79(5):1130-6. PubMed ID: 1536941
[TBL] [Abstract][Full Text] [Related]
19. Treatment of multiple myeloma with autologous blood stem cell transplantation. Preliminary results of an Italian multicentric pilot study.
Tribalto M; Papa G; Coppetelli U; Adorno G; Caravita T; Dentamaro T; Rainone A; Avvisati G; La Verde G; Leone G
Int J Artif Organs; 1993 Dec; 16 Suppl 5():51-6. PubMed ID: 7516917
[TBL] [Abstract][Full Text] [Related]
20. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?
Philip T; Zucker JM; Bernard JL; Lutz P; Bordigoni P; Plouvier E; Robert A; Roché H; Souillet G; Bouffet E
J Clin Oncol; 1991 Jun; 9(6):1037-44. PubMed ID: 2033417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
